BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Med’s Industry

Codex Genetics and Pacific Edge Partner to Introduce Cxbladder Genomic Urine Tests for Bladder Cancer Diagnosis in Hong Kong

Codex Genetics, one of the leading precision diagnostics companies in Hong Kong, announced an exclusive collaboration with Pacific Edge, the deve...

August 11, 2025 | News

AXA Partners with Hainan Boao Lecheng to Pioneer Innovative Cross-Border Medical Insurance Models

AXA China Region Insurance Company (Bermuda) Limited ("AXA") formally signed an official cooperation agreement with Hainan Boao Lecheng Internati...

August 11, 2025 | News

Anbio Expands Point-of-Care Arsenal with Rapid Chikungunya Test and Ultra-Fast PCR Platform to Combat Global Outbreaks

Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detectio...

August 11, 2025 | News

UK’s First AI Tool to Predict Hospital Infections Secures CE Mark, MHRA Approval

AI tool that spots hospital infections up to 72 hours early, newly backed by former health minister Lord Bethell, Prof Carole Longson and Dr Ar...

August 06, 2025 | News

Innovent Biologics gets FDA nod to begin Phase 1 trials of oral GLP-1R agonist IBI3032

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

August 05, 2025 | News

Precision Therapies Set to Unlock USD 1.6 Trillion in Economic Impact Across Asia-Pacific

As Asia-Pacific bears nearly half of the global cancer burden, precision medicine is emerging not only as a clinical breakthrough but also as a powerful ec...

August 04, 2025 | Interview

Eflornithine Added to Australia’s PBS for Children with High-Risk Neuroblastoma

Eflornithine is now reimbursed by the government under Australia's Pharmaceutical Benefits Scheme (PBS). The Pharmaceutical Benefits Advisory C...

August 04, 2025 | News

VB Spine Expands Globally with Acquisition of Stryker’s Spinal Implants Business in Australia and New Zealand

Stryker’s spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor...

August 01, 2025 | News

Quanterix Launches First-to-Market p‑Tau 205 and 212 Assays, Expanding Alzheimer’s Biomarker Portfolio

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, announced the first to market, com...

August 01, 2025 | News

Leo Cancer Care’s Marie® Secures FDA 510(k) Clearance, Pioneering Upright Particle Therapy in the U.S.

Leo Cancer Care, a leader in upright radiotherapy solutions, announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. F...

July 31, 2025 | News

Alamar Biosciences and Germany’s DZNE Join Forces to Advance Early Detection of Neurodegenerative Diseases

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced a strategic collaboration with the Germa...

July 31, 2025 | News

Johor’s Healthcare Transformation: Billions Poured into Malaysia’s Life Sciences Engine (2022–2025)

Johor’s Healthcare & Life Sciences Investment Boom (2022–2025) Over the past three years, the southern Malaysian state of Johor has emerge...

July 30, 2025 | Report

Suzhou’s Kintor Pharma Reports Positive Phase II Results for KX-826 in AGA Trial, Clears Path for Phase III

Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and po...

July 28, 2025 | News

Revival Healthcare Capital and Olympus Launch $458M Joint Venture to Advance GI Robotics Innovation

Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships in MedTech is, pleased to announce a st...

July 28, 2025 | News

Stay Connected